A single-cell RNA-sequencing atlas of over 2 million cells from 116 CTCL patients reveals recurrent oncogenic transcriptional programs and immune escape mechanisms.
Cutaneous lymphoproliferative disorders research
Moving in Blood and Nature Medicine.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 2
Add Cutaneous lymphoproliferative disorders research as an interest in JClubFree on iPhone and Android · interests shape Home, Discover and your digest
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Cutaneous lymphoproliferative disorders research
Newest first · last 60 days
CD19 CAR T cell therapy demonstrated acceptable safety and significant clinical improvements in six patients with treatment-refractory seropositive rheumatoid arthritis, with a median 34% DAS28-CRP reduction.
Add Cutaneous lymphoproliferative disorders research as an interest in JClub
Browse JClub
Journals this month
- bioRxiv6183
- medRxiv1716
- PNAS472
- Sci Adv398
- JAMA274
- Environ Res230
- BMJ200
- Nat Commun171
- Environ Pollution165
- Nature161
- NEJM146
- Science141
- Lancet132
- Cell Rep130
- Curr Biol108
- J Exp Bot108
- mBio107
- Plant Cell Environ107
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3